|
DE431291C
(de)
|
1925-03-29 |
1926-07-08 |
Contessa Nettel A G |
Wechselkassette mit herausziehbarer Wechsellade
|
|
US1936364A
(en)
|
1930-08-22 |
1933-11-21 |
Pfizer Charles & Co |
Citrate solutions
|
|
US2260004A
(en)
|
1939-11-03 |
1941-10-21 |
Pfizer Charles & Co |
Stable soluble magnesium acid citrate
|
|
US2938891A
(en)
|
1956-03-30 |
1960-05-31 |
Roussel Uclaf |
Method of making oxytocin and intermediates thereof
|
|
US3076797A
(en)
|
1957-07-22 |
1963-02-05 |
Roussel Uclaf |
Process of producing oxytocin and intermediates obtained thereby
|
|
US4213968A
(en)
|
1978-06-05 |
1980-07-22 |
Coy David Howard |
Enkephalin derivatives
|
|
US4464378A
(en)
|
1981-04-28 |
1984-08-07 |
University Of Kentucky Research Foundation |
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
|
|
US4486441A
(en)
|
1982-12-03 |
1984-12-04 |
Merrell Toraude Et Compagnie |
Pseudotropyl halogeno-benzoates and their use in migraine treatment
|
|
JPS59163313A
(ja)
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
|
ATE78158T1
(de)
|
1985-05-22 |
1992-08-15 |
Liposome Technology Inc |
Verfahren und system zum einatmen von liposomen.
|
|
HU906340D0
(en)
|
1986-10-13 |
1991-04-29 |
Sandoz Ag |
Synthesis in solid phase for producing peptonic alcohols
|
|
KR890006252A
(ko)
|
1987-10-15 |
1989-06-12 |
헤르비그 폰 모르체 |
분말형 폴리펩타이드의 비강내 투여용 조성물 및 투여방법
|
|
US4885287A
(en)
|
1988-08-09 |
1989-12-05 |
University Of Kentucky Research Foundation |
Novel method of administering aspirin and dosage forms containing same
|
|
US6407061B1
(en)
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
|
ATE156704T1
(de)
|
1989-12-05 |
1997-08-15 |
Ramsey Foundation |
Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
|
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
|
US5460972A
(en)
|
1991-04-08 |
1995-10-24 |
Research Foundation Of The State University Of New York |
Ionized magnesium2+ concentrations in biological samples
|
|
GB9202464D0
(en)
|
1992-02-05 |
1992-03-18 |
Danbiosyst Uk |
Composition for nasal administration
|
|
GB9203769D0
(en)
|
1992-02-21 |
1992-04-08 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
GB9211268D0
(en)
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
|
SE9300937L
(sv)
|
1993-03-19 |
1994-09-20 |
Anne Fjellestad Paulsen |
Komposition för oral administrering av peptider
|
|
DE69434418T2
(de)
|
1993-04-22 |
2005-12-22 |
Emisphere Technologies, Inc. |
Orale Dareichungsform
|
|
US5482931A
(en)
|
1993-06-29 |
1996-01-09 |
Ferring Ab |
Stabilized pharmaceutical peptide compositions
|
|
US5837809A
(en)
|
1995-08-11 |
1998-11-17 |
Oregon Health Sciences University |
Mammalian opioid receptor ligand and uses
|
|
US6054462A
(en)
|
1994-04-13 |
2000-04-25 |
Janssen Pharmaceutica, N.V. |
Intranasal antimigraine compositions
|
|
JP3414539B2
(ja)
|
1994-05-11 |
2003-06-09 |
有限会社ドット |
経鼻吸収用組成物
|
|
WO1996020001A1
(en)
|
1994-12-28 |
1996-07-04 |
Teikoku Hormone Mfg. Co., Ltd. |
Transmucosal preparation
|
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
|
CA2247191C
(en)
|
1996-02-27 |
2005-01-04 |
Teijin Limited |
Powdery composition for nasal administration
|
|
DE19627228A1
(de)
|
1996-07-05 |
1998-01-08 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5798266A
(en)
|
1996-08-27 |
1998-08-25 |
K-Quay Enterprises, Llc |
Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
|
|
US5855907A
(en)
|
1997-03-24 |
1999-01-05 |
Peyman; Gholam A. |
Method of treatment of migraine
|
|
SE9701162D0
(sv)
|
1997-03-27 |
1997-03-27 |
Karolinska Innovations Ab |
New use II
|
|
SE9701161D0
(sv)
|
1997-03-27 |
1997-03-27 |
Karolinska Innovations Ab |
New use I
|
|
AU8333998A
(en)
|
1997-07-15 |
1999-02-10 |
Novo Nordisk A/S |
New use of nociceptin
|
|
US6432986B2
(en)
|
1997-07-21 |
2002-08-13 |
Bruce H. Levin |
Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
|
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US6143278A
(en)
|
1998-02-23 |
2000-11-07 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
|
US6090368A
(en)
|
1998-03-03 |
2000-07-18 |
The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations |
Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
|
|
EP1950224A3
(en)
|
1998-03-09 |
2008-12-17 |
Zealand Pharma A/S |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
US6068999A
(en)
|
1998-06-25 |
2000-05-30 |
Hendrix; Curt |
Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
|
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
|
JP2002531489A
(ja)
|
1998-12-09 |
2002-09-24 |
カイロン コーポレイション |
中枢神経系への神経栄養剤の投与
|
|
JP2002531490A
(ja)
|
1998-12-09 |
2002-09-24 |
カイロン コーポレイション |
中枢神経系に薬剤を投与するための方法
|
|
US7273618B2
(en)
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
|
US6139861A
(en)
|
1999-01-14 |
2000-10-31 |
Friedman; Mark |
Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
|
|
KR20020016831A
(ko)
|
1999-06-16 |
2002-03-06 |
나스텍 파마수티컬 컴퍼니 인코포레이티드 |
비내용 모르핀을 함유하는 의약 조성물 및 그 제조방법
|
|
JP2001002589A
(ja)
|
1999-06-18 |
2001-01-09 |
Teijin Ltd |
穏やかな薬物血中濃度の上昇を可能とする経鼻投与用組成物
|
|
JP2001089359A
(ja)
|
1999-09-24 |
2001-04-03 |
Toko Yakuhin Kogyo Kk |
鎮痛成分の点鼻用ゲルまたはゾル製剤
|
|
AU8003800A
(en)
|
1999-10-08 |
2001-04-23 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
CA2325106A1
(en)
|
1999-12-06 |
2001-06-06 |
Stanley L. Gore |
Compositions and methods for intranasal delivery of active agents to the brain
|
|
DE60021760T2
(de)
|
1999-12-09 |
2006-06-08 |
Chiron Corp., Emeryville |
Verfahren zur verabreichung von wirkstoffen in das zentrale nervensystem oder lymphsystem
|
|
ATE290856T1
(de)
|
1999-12-16 |
2005-04-15 |
Dermatrends Inc |
Hydroxide freisetzende verbindungen zum verbessern der hautdurchlässigkeit
|
|
US6413499B1
(en)
|
2000-01-06 |
2002-07-02 |
Bryan M. Clay |
Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
|
|
US20070032410A1
(en)
|
2000-01-11 |
2007-02-08 |
Atossa Healthcare, Inc. |
Compositions and methods for the treatment of psychiatric disorders
|
|
JP2001233787A
(ja)
|
2000-02-04 |
2001-08-28 |
Patents Exploitation Co Bv |
小・中サイズのペプチド含有薬学的組成物
|
|
EP1121935B1
(en)
|
2000-02-04 |
2008-08-13 |
Patents Exploitation Company B.V. |
Pharmaceutical composition containing a small or medium size peptide
|
|
WO2001079263A1
(en)
|
2000-04-14 |
2001-10-25 |
Nippon Shinyaku Co., Ltd. |
Peptide derivatives and medicinal compositions
|
|
AU2001257326A1
(en)
|
2000-04-28 |
2001-11-12 |
Memorial Sloan-Kettering Cancer Center |
Topical anesthetic/opioid formulations and uses thereof
|
|
US7084126B1
(en)
|
2000-05-01 |
2006-08-01 |
Healthpartners Research Foundation |
Methods and compositions for enhancing cellular function through protection of tissue components
|
|
AU2001262992A1
(en)
|
2000-05-10 |
2002-02-18 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of opioids
|
|
IL137820A
(en)
|
2000-08-10 |
2009-06-15 |
S I S Shulov Inst For Science |
Pharmaceutical composition for topical administration comprising an analgesic peptide
|
|
AU2002211688A1
(en)
|
2000-10-13 |
2002-04-29 |
Chiron Corporation |
Method for treating ischemic events affecting the central nervous system
|
|
US20070112052A9
(en)
|
2001-01-05 |
2007-05-17 |
Larry Caldwell |
Methods and compositions for treating headache pain with topical NSAID compositions
|
|
DE60236496D1
(de)
|
2001-03-23 |
2010-07-08 |
Einstein Coll Med |
Verfahren zur erhöhung der analgetischen wirkung und zur verringerung der unerwünschten exitatorischen wirkungen von bimodalisch wirksamen opioidagonisten durch die hemmung von gm1-gangliosid
|
|
US20020169102A1
(en)
|
2001-04-03 |
2002-11-14 |
Frey William H. |
Intranasal delivery of agents for regulating development of implanted cells in the CNS
|
|
JP2004532849A
(ja)
|
2001-04-20 |
2004-10-28 |
カイロン コーポレイション |
中枢神経系へのポリヌクレオチド薬剤の送達
|
|
US7820688B2
(en)
|
2001-04-27 |
2010-10-26 |
Memorial Sloan-Kettering Cancer Center |
Topical anesthetic/opioid formulations and uses thereof
|
|
SE0102184D0
(sv)
|
2001-06-19 |
2001-06-19 |
Uvnaes Moberg Kerstin |
New subject-matter
|
|
AU2002349513B2
(en)
*
|
2001-11-26 |
2007-10-18 |
Asubio Pharma Co., Ltd. |
Medicinal compositions for nasal absorption
|
|
US20030104085A1
(en)
|
2001-12-05 |
2003-06-05 |
Yeomans David C. |
Methods and compositions for treating back pain
|
|
JP2005524649A
(ja)
|
2002-02-25 |
2005-08-18 |
カイロン コーポレーション |
Ｍｃ４−ｒアゴニストの鼻腔内投与
|
|
US7666876B2
(en)
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
|
US20040105889A1
(en)
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
CA2785889A1
(en)
|
2002-04-22 |
2003-10-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide inhibitors of protein kinase c
|
|
GB0209494D0
(en)
|
2002-04-25 |
2002-06-05 |
Optinose As |
Nasal devices
|
|
ES2348604T3
(es)
|
2002-04-29 |
2010-12-09 |
Euro-Celtique S.A. |
Péptidos conformacionalmente restringidos que se unen al receptor orl-1.
|
|
WO2003093816A2
(en)
|
2002-05-02 |
2003-11-13 |
Bayer Healtchare Ag |
Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
|
|
EP2283864A1
(en)
|
2002-07-16 |
2011-02-16 |
Elan Pharma International Ltd. |
Liquid dosage compositions fo stable nanoparticulate active agents
|
|
WO2004019875A2
(en)
|
2002-08-30 |
2004-03-11 |
Board Of Regents, The University Of Texas System |
Non-invasive methods to identify agents for treating pain
|
|
ITMI20022022A1
(it)
|
2002-09-24 |
2004-03-25 |
Girolamo Calo' |
Analoghi di nocicettina.
|
|
ES2353690T3
(es)
*
|
2002-10-03 |
2011-03-04 |
Neuropharmacology Services, Llc |
Oxitocina para su uso en el tratamiento del autismo y del trastorno de asperger.
|
|
WO2004062563A2
(en)
|
2003-01-16 |
2004-07-29 |
Université de Lausanne |
Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders
|
|
US20070016968A1
(en)
|
2003-02-19 |
2007-01-18 |
Stephanos Kyrkanides |
Treatment of pain through expression of opioid receptors
|
|
ES2315455T3
(es)
|
2003-03-27 |
2009-04-01 |
Pantarhei Bioscience B.V. |
Uso de estrogenos para el tratamiento de infertilidad en maniferos machos.
|
|
WO2005046569A2
(en)
|
2003-04-08 |
2005-05-26 |
Biotempt B.V. |
Pharmaceutical compositions for the treatment of sars
|
|
GB0319119D0
(en)
|
2003-08-14 |
2003-09-17 |
Optinose As |
Delivery devices
|
|
US20050153885A1
(en)
|
2003-10-08 |
2005-07-14 |
Yun Anthony J. |
Treatment of conditions through modulation of the autonomic nervous system
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
US20050228023A1
(en)
|
2003-12-19 |
2005-10-13 |
Sri International |
Agonist and antagonist ligands of the nociceptin receptor
|
|
WO2005115370A2
(en)
|
2004-04-23 |
2005-12-08 |
The Regents Of The University Of California |
Compounds and methods for treating non-inflammatory pain using pparalpha agonists
|
|
EP1604655A1
(en)
|
2004-06-09 |
2005-12-14 |
Schwarz Pharma Ag |
Novel use of peptide compounds for treating pain in trigeminal neuralgia
|
|
US7618615B2
(en)
|
2004-08-13 |
2009-11-17 |
Healthpartners Research Foundation |
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
|
US7151084B2
(en)
|
2004-12-27 |
2006-12-19 |
Miller Landon C G |
Compound and method of treating neurogenic conditions using non-steroidal anti-inflammatory drug complexes
|
|
CA2588292C
(en)
|
2004-12-01 |
2019-01-15 |
Health Protection Agency |
Non-cytotoxic protein conjugates
|
|
WO2006091332A2
(en)
|
2005-02-23 |
2006-08-31 |
Alza Corporation |
Intranasal administration of active agents to the central nervous system
|
|
CN101193626A
(zh)
|
2005-03-11 |
2008-06-04 |
益德威士医药股份有限公司 |
奥曲肽的受控释放制剂
|
|
US20060252685A1
(en)
|
2005-05-04 |
2006-11-09 |
Gould Jeffrey D |
Treatment for sleep apnea
|
|
EP1928484B1
(en)
|
2005-08-26 |
2010-02-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treatment of headaches by administration of oxytocin
|
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
|
DK1984009T3
(da)
*
|
2006-01-18 |
2013-01-28 |
Qps Llc |
Farmaceutiske sammensætninger med forbedret stabilitet
|
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
|
US9023793B2
(en)
*
|
2006-09-29 |
2015-05-05 |
Retrophin, Inc. |
Intranasal carbetocin formulations and methods for the treatment of autism
|
|
US8142803B2
(en)
|
2007-03-22 |
2012-03-27 |
Magceutics, Inc. |
Magnesium compositions and uses thereof for neurological disorders
|
|
NZ581452A
(en)
*
|
2007-06-07 |
2012-11-30 |
Kyalin Bioscience Inc |
Intranasal carbetocin formulations and methods for the treatment of autism
|
|
US9808509B2
(en)
|
2007-06-08 |
2017-11-07 |
Healthpartners Research Foundation |
Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
|
|
JP2009073744A
(ja)
|
2007-09-19 |
2009-04-09 |
Saitama Medical Univ |
片頭痛の予防治療剤
|
|
EP2161030A1
(en)
|
2008-09-09 |
2010-03-10 |
Rijksuniversiteit te Groningen |
Oxytocin formulations and uses thereof
|
|
JP5467785B2
(ja)
|
2009-03-25 |
2014-04-09 |
大塚製薬株式会社 |
抗鳥インフルエンザウイルス抗体の産生促進剤
|
|
KR20180052610A
(ko)
|
2009-07-27 |
2018-05-18 |
노시셉터 엘엘씨 |
통증 치료 방법
|
|
JP5491119B2
(ja)
|
2009-10-02 |
2014-05-14 |
日東電工株式会社 |
薬物含有微粒子を含む医薬組成物およびその製造方法
|
|
US20130130985A1
(en)
|
2010-04-01 |
2013-05-23 |
Paul Alewood |
Oxytocin peptide analogues
|
|
EP2571360A4
(en)
*
|
2010-05-19 |
2013-07-31 |
Univ North Carolina |
METHOD AND FORMULATIONS FOR OXYTOCIN TREATMENT OF DRUG ABUSE AND PSYCHIATRIC AND OTHER DISORDERS
|
|
AU2011264416A1
(en)
|
2010-06-07 |
2013-01-10 |
The University Of Queensland |
Nociceptin mimetics
|
|
WO2012016229A2
(en)
|
2010-07-30 |
2012-02-02 |
The Regents Of The University Of California |
Oxytocin treatment to improve memory and modify blood glucose
|
|
JO3400B1
(ar)
|
2010-09-30 |
2019-10-20 |
Ferring Bv |
مركب صيدلاني من كاربيتوسين
|
|
US20120252894A1
(en)
|
2011-04-01 |
2012-10-04 |
Giniatullin Rashid |
Compounds for alleviating pain and stress in fetus and newborn
|
|
SE536091C2
(sv)
|
2011-04-14 |
2013-04-30 |
Pep Tonic Medical Ab |
Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
|
|
US20140045702A1
(en)
*
|
2012-08-13 |
2014-02-13 |
Synapdx Corporation |
Systems and methods for distinguishing between autism spectrum disorders (asd) and non-asd development delay
|
|
EP2908840A1
(en)
|
2012-10-12 |
2015-08-26 |
Peptonic Medical AB |
Novel use of a composition comprising oxytocin
|
|
US20140147519A1
(en)
|
2012-11-26 |
2014-05-29 |
Larry A. MCPHAIL |
Migraine Treatment
|
|
EP2845850A1
(en)
*
|
2013-09-10 |
2015-03-11 |
ObsEva S.A. |
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
|
|
JP7030517B2
(ja)
|
2015-01-07 |
2022-03-07 |
トライジェミナ， インコーポレイテッド |
マグネシウム含有オキシトシン製剤および使用の方法
|